Here, we provide evidence that transfer of gene-corrected hematopoietic progenitors can correct innate immune responses associated with XIAP deficiency in a murine model, which could translate to therapeutic benefit. The gene discussed is XIAP; the disease is hyperinsulinemic hypoglycemia, familial, 4.